Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
30.04
+0.77 (2.65%)
May 13, 2026, 12:00 PM EDT - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $97.77 million as of May 13, 2026. Its market cap has increased by 100.36% in one year.
Market Cap
97.77M
Enterprise Value
71.22M
1-Year Change
100.36%
Ranking
Category
Stock Price
$30.04
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $97.77M, a decrease of -49.47%. That is a compound annual growth rate of -7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 95.30M | 297.08% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 102.69M |
| Coya Therapeutics | 100.63M |
| Anixa Biosciences | 98.91M |
| Q32 Bio | 98.52M |
| Vivani Medical | 98.31M |
| enGene Therapeutics | 96.46M |
| LeonaBio | 95.53M |
| NeurAxis | 95.15M |